Medline Inc. (MDLN) income statement
MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3068% above fair value
$37.84−1.32 (-3.37%)
Close on Nov 19, 2026Market cap $49.75BP/E –Yield –
Medline Inc. income statement
Ratios
Latest available, balances at Sep 26, 2026
Profitability, TTM
- Gross margin
- 25.7%
- Operating margin
- 5.7%
- Net margin
- 3.8%
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 4.04
- Debt to equity
- 1.07
- Debt to assets
- 31.3%
- Cash to current liabilities
- 74.2%
Valuation
- P/E ratio
- –
- Price to sales
- 1.62
- Price to book
- 4.22
- Dividend yield
- –
See a number that looks wrong?